ATCC Launches New PCR-Based Mycoplasma Detection Service

Ensures validity and reliability of data from cell culture-based research MANASSAS, Va., (July 10, 2018) — ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, today announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing... Read more

Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics Co., Ltd (“Dian”), one of China’s largest independent medical laboratories provider. The strategic agreement will enable Dian to promote and broadly commercialize Agena’s MassARRAY® System and DNA testing applications and products throughout... Read more

PerkinElmer and Women & Infants Hospital of Rhode Island Launch Trial to Evaluate Performance Characteristics for High-Volume Non-Invasive Prenatal Testing Platform

International Conference on Prenatal Diagnosis and Therapy (ISPD), Booth #15,  Antwerp, Belgium – July 10, 2018 – PerkinElmer, Inc.,  a global leader committed to innovating for a healthier world, today announced a collaboration with Women & Infants Hospital (WIH) of Rhode Island, a Care New England hospital, to evaluate an innovative test method using the... Read more

Heal to Offer Advanced Diagnostic Tests to U.S. Allergy Sufferers During Convenient House Calls

Heal to Offer Advanced Diagnostic Tests to U.S. Allergy Sufferers During Convenient House Calls Physicians can now order and obtain Thermo Fisher Scientific allergic sensitization tests for patients in connection with in-home or in-office visits, helping diagnose and treat respiratory and food allergies more personally and conveniently KALAMAZOO, Mich., July 10, 2018 /PRNewswire/ — Heal, a... Read more

BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease

FRANKLIN LAKES, N.J., July 9, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis. In the U.S. alone, there are... Read more

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions UPPSALA, Sweden, July 6, 2018 /PRNewswire/ — A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is... Read more

Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio

Oncomine TCR Beta-SR Assay for next-generation sequencing enables site-specific interrogation for T-cell receptor applications CARLSBAD, Calif., June 28, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of its Oncomine TCR Beta-SR Assay, a new next-generation sequencing (NGS) solution for immuno-oncology research designed to characterize T-cell clonality in the tumor microenvironment – a key approach... Read more